David Mayman
Orthopaedic Surgery · New York, NYNPI 1407882921
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $4,688,488 of the $5,467,346 with a category attached, or 85.8%. Stryker accounts for 60.0% of it on its own, with 14 other manufacturers making up the rest. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 496 payments — averaging $11,023 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3.3M
- Smith+Nephew$1.1M
- Orthalign Inc$597K
- Encore Medical, LP$528K
- Globus Medical$414
- Wishbone Medical Inc.$122
- plus $424 from 9 others
Across 31 payments — averaging $25,416 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$788K
Across 8 payments — averaging $7749.99 each. An ownership or investment interest held by the physician or an immediate family member.
- Orthalign Inc$62K
- Insight Medical Systems, Inc.$0
What the payments were for
- Royalty or licence$4,688,48886%
- Consulting fees$167,2663%
- Speaking & faculty fees$24,6850%
- Travel & lodging$46,5281%
- Food & beverage$12,0050%
- Other$528,37410%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 320 | $3,281,862 |
| Smith+Nephew | 114 | $1,058,781 |
| Orthalign Inc | 46 | $597,368 |
| Encore Medical, LP | 1 | $528,374 |
| Globus Medical | 1 | $414 |
| Wishbone Medical Inc. | 1 | $122 |
| KCI USA, Inc. | 1 | $108 |
| Overture Orthopaedics | 1 | $62 |
| Medical Device Business Services, Inc. | 2 | $56 |
| Convatec Inc. | 1 | $53 |
| Ferring Pharmaceuticals Inc. | 3 | $49 |
| Insight Medical Systems, Inc. | 2 | $45 |
| Bone Support Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$2,986,602
- NAVIO$701,872
- ORTHALIGN PLUS$556,542
- Journey II$427,904
- REAL INTELLIGENCE$275,795
- INSIGNIA$233,531
- Navio Surgical System$55,578
- OrthAlign Plus System$40,548
- TRIATHLON$25,528
- Journey II BCS$11,809
- Journey II CR$10,338
- Journey II XR$8,808
- NA$6,022
- TRIDENT$1,538
- REUNION$1,500
- ACCOLADE$1,375
- RESTORATION$1,375
- RESTORIS$1,250
- LEGION TKS$1,006
- AEQUALIS$1,000
How this compares
$5,467,346 in reported general payments places this provider in the 95th percentile of 1,079 orthopaedic surgery providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 21 | $64 |
| Amoxicillin | 16 | $34 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in New York
- Anthony RomeoNew York$26.8M
- Lawrence LenkeNew York$26.8M
- Edwin SuNew York$13.2M
- William RicciNew York$11.6M
- Steven HaasNew York$11.3M
- Giles ScuderiNew York$10.7M
- Joseph ZuckermanNew York$9.9M
- Evan FlatowNew York$9.6M
- Bradford ParsonsNew York$9.4M
- Geoffrey WestrichNew York$7.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.